This is a 1 year study looking at a new medication (Tanezumab) for treatment of chronic low back pain. Subjects must be 18 years of age or older and must have had low back pain for at least 3 months. Also subjects must have pain despite treatment with Tylenol, opiates or NSAID’s. Subjects are excluded if they have osteoarthritis of the hip, knee or shoulder.
If interested in hearing more about this study please contact Christine Lewis, RN Chris@AlpineResearch.com